| Nov 15 |
Bio-Path Holdings, Inc. (BPTH) Q3 2024 Earnings Call Transcript
|
| Nov 15 |
Bio-Path: Q3 Earnings Snapshot
|
| Nov 15 |
Bio-Path GAAP EPS of -$0.70
|
| Nov 15 |
Bio-Path Holdings Reports Third Quarter 2024 Financial Results
|
| Nov 15 |
Earnings Scheduled For November 15, 2024
|
| Nov 14 |
Bio-Path Q3 2024 Earnings Preview
|
| Oct 9 |
Bio-Path Holdings Inc (BPTH) Q2 2024 Earnings Call Highlights: Financial Improvements and ...
|
| Oct 9 |
Bio-Path announces $4M private placement
|
| Oct 8 |
ACHR, BPTH, PLUG, REGRF:
|
| Oct 8 |
Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer
|
